Table 1 Lesion characteristics in the EUS-LA and US-LA groups
US-LA (n = 100) | EUS-LA (n = 20) | p value | |
|---|---|---|---|
History of thermal ablation/Y | 67 (67.0%) | 16 (80.0%) | 0.250 |
Multiple hepatic tumours/Y | 64 (64.0%) | 9 (45.0%) | 0.112 |
Tumour diagnosis/HCC | 77 (77.0%) | 12 (60.0%) | 0.113 |
Poorly differentiated tumour/Y | 22 (22.0%) | 3 (15.0%) | 0.482 |
Recurrent lesion/Y | 88 (88.0%) | 20 (100%) | 0.102 |
High-risk position/Y | 56 (56.0%) | 14 (70.0%) | 0.246 |
Tumour position/left lobe | 28 (28.0%) | 18 (90.0%) | < 0.01 |
Maximum tumour diameter/mean ± SD, cm | 1.72 ± 0.58 | 1.79 ± 0.75 | 0.676 |
Multi-fibre technique/Y | 69 (69.0%) | 0 (0%) | < 0.01 |
Multi-session ablation/Y | 4 (4.0%) | 4 (20.0%) | 0.009 |
Delivered energy/mean ± SD, J | 2927.94 ± 1690.50 | 2449.00 ± 1579.08 | 0.245 |